EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Diabetic Peripheral Neuropathy: Current Epidemiology, Diagnostic Advances, Biomarkers, and Management Strategies

Felix T Kurz, Johann M Jende, Rares Salomir, Karl-Olof Lövblad, Agustina Lascano, Karim Gariani iD

Journal of Diabetes Research · 2026-01 · 2026 (1)

DOI: 10.1155/jdr/9080699 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Diabetes Research, online erschienen am 21.04.2026. Verfasst von Felix T Kurz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroradiology, Geneva University Hospitals, Geneva, Switzerland, hug-ge.ch. Hauptthemen laut MEDLINE: Diabetic Neuropathies. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Universite de Geneve, Consortium Of Swiss Academic Libraries.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic peripheral neuropathy (DPN) is one of the most common and disabling complications of diabetes mellitus (DM), affecting up to 50% of patients during the course of their disease. The condition manifests predominantly as a distal symmetric polyneuropathy, with early involvement of small fibers and progressive sensory loss. Epidemiological data show high prevalence not only in type 1 and type 2 diabetes but also in prediabetic populations, highlighting the need for early detection. The pathophysiology of DPN is complex, involving metabolic dysregulation, oxidative stress, vascular insufficiency, inflammation, and mitochondrial dysfunction. Diagnostic tools range from clinical examination and nerve conduction studies (NCS) to magnetic resonance imaging. Recent advances in plasma and neuroimaging biomarkers offer promising avenues for earlier and more accurate diagnosis. Management focuses on strict glycemic control, risk factor modification, symptomatic treatment of neuropathic pain, and lifestyle interventions. Despite ongoing research, no curative therapy currently exists, underscoring the urgent need for disease‐modifying strategies. A multidisciplinary, patient‐centered approach is essential to mitigate complications and improve quality of life. This review provides a comprehensive overview of DPN, covering its epidemiology, pathogenesis, diagnostic approaches, emerging biomarkers, and current management strategies. Future research should emphasize biomarker validation, longitudinal monitoring, and personalized therapeutic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NeuropathiesHumansBiomarkersRisk FactorsNerve Conduction StudiesDiabetes Mellitus, Type 2

Stichwörter der Autor:innen

autonomic dysfunctiondiabetesdiabetes-related complicationsdiabetic neuropathydiagnostic toolsimagingmagnetic resonance imagingneuropathic painsmall fiber neuropathy

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Neuroradiology, Geneva University Hospitals, Geneva, Switzerland, hug-ge.ch.
  • Division of Radiology, German Cancer Research Center, Heidelberg, Germany, dkfz.de.
  • Division of Radiology, Diagnostic Department, Geneva University Hospital, 1211, Geneva, Switzerland, hug-ge.ch.
  • Image Guided Interventions Laboratory (GR-949), Faculty of Medicine, University of Geneva, 1211, Geneva, Switzerland, unige.ch.
  • Department of Clinical Neurosciences, Division of Neurology, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland, unige.ch.
  • Division of Endocrinology, Diabetes and Metabolism, Department of Medical Specialties, Geneva University Hospitals, Geneva, 1205, Switzerland, hug-ge.ch.

ORCID-Profile: Karim Gariani

Förderung

  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • Universite de Geneve
  • Consortium Of Swiss Academic Libraries

Zitieren

APA

Kurz, F. T., Jende, J. M., Salomir, R., Lövblad, K. O., Lascano, A., & Gariani, K. (2026). Diabetic Peripheral Neuropathy: Current Epidemiology, Diagnostic Advances, Biomarkers, and Management Strategies. Journal of Diabetes Research, 2026(1). https://doi.org/10.1155/jdr/9080699

Vancouver

Kurz FT, Jende JM, Salomir R, Lövblad KO, Lascano A, Gariani K. Diabetic Peripheral Neuropathy: Current Epidemiology, Diagnostic Advances, Biomarkers, and Management Strategies. Journal of Diabetes Research. 2026;2026(1). doi:10.1155/jdr/9080699

BibTeX
@article{Kurz2026,
  author = {Kurz, Felix T and Jende, Johann M and Salomir, Rares and Lövblad, Karl-Olof and Lascano, Agustina and Gariani, Karim},
  title = {Diabetic Peripheral Neuropathy: Current Epidemiology, Diagnostic Advances, Biomarkers, and Management Strategies},
  journal = {Journal of Diabetes Research},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/jdr/9080699}
}
Kostenlos starten →